Skip to content

Member

Tiemo WÖLKEN

S&D · Germany

Group
S&D
Country
Germany
Roll-call participation
69.2 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line
96.7 %ⓘ of 429 votes where the group had a line · S&D median 97.1 %
More facts (5)
National party
SPD Sozialdemokratische Partei Deutschlands
In office
Since 16 Jul 2024
Against clear line
10 of 423 votesⓘ
Committees
ENVI, JURI (substitute), SANT
Member id
185619
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

69.2 %

429 of 620 final votes while in office

S&D median: 89.5 % (−20.3 pts)

Chamber median: 90.6 %

With majority line ⓘ

96.7 %

415 of 429 votes where their group had a line

S&D median: 97.1 % (−0.4 pts)

Against clear line ⓘ

2.4 %

10 of 423 votes where their group had a clear line

4 opposite (for ↔ against), 6 abstained against the line

Abstention ⓘ

2.6 %

11 of 429 votes cast

Participation 69.2 % — S&D median 89.5 %, 137 members.ⓘ
Data as a table
Participation among the 137 members of the S&D with enough votes.
FigureParticipation
Tiemo WÖLKEN69.2 %
S&D median89.5 %
Lowest in the group48.1 %
Highest in the group99.8 %
Members137
With majority line 96.7 % — S&D median 97.1 %, 137 members.ⓘ
Data as a table
With majority line among the 137 members of the S&D with enough votes.
FigureWith majority line
Tiemo WÖLKEN96.7 %
S&D median97.1 %
Lowest in the group86.7 %
Highest in the group99.8 %
Members137
  • Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of S&D; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
17 Sept 2026Evaluation of the Common Fisheries Policy and follow-up Amendment 5 to paragraph 4 138 for, 468 against, 2 abstainedPosition: Against Majority line: Against
17 Sept 2026Evaluation of the Common Fisheries Policy and follow-up Paragraph 2 — part 2 461 for, 130 against, 15 abstainedPosition: Against ≠ groupMajority line: For
17 Sept 2026Evaluation of the Common Fisheries Policy and follow-up Amendment 4 to paragraph 2 128 for, 469 against, 14 abstainedPosition: For ≠ groupMajority line: Against
17 Sept 2026Evaluation of the Common Fisheries Policy and follow-up Amendment 3, adding text after paragraph 1 248 for, 294 against, 60 abstainedPosition: For Majority line: For
17 Sept 2026Evaluation of the Common Fisheries Policy and follow-up Paragraph 1 — part 2 478 for, 117 against, 11 abstainedPosition: For Majority line: For
17 Sept 2026Evaluation of the Common Fisheries Policy and follow-up Amendment 2 to paragraph 1 134 for, 436 against, 35 abstainedPosition: For ≠ groupMajority line: Against
17 Sept 2026The role of social, economic and environmental standards in safeguarding fair competition for all aquatic food products and improving food security Final vote on the motion for a resolutionAdopted 467 for, 92 against, 44 abstainedPosition: For Majority line: For
17 Sept 2026Impact of social media and the online environment on young people Final vote — text as a wholeAdopted 395 for, 136 against, 80 abstainedPosition: For Majority line: For
17 Sept 2026Impact of social media and the online environment on young people Recital AD — part 2 413 for, 143 against, 50 abstainedPosition: For Majority line: For
17 Sept 2026Impact of social media and the online environment on young people Recital AD — part 1 575 for, 13 against, 19 abstainedPosition: For Majority line: For
17 Sept 2026Impact of social media and the online environment on young people Paragraph 85 — part 2 403 for, 146 against, 50 abstainedPosition: For Majority line: For
17 Sept 2026Impact of social media and the online environment on young people Paragraph 85 — part 1 449 for, 100 against, 62 abstainedPosition: For Majority line: For
17 Sept 2026Impact of social media and the online environment on young people Paragraph 63 — part 3 401 for, 181 against, 29 abstainedPosition: Abstained ≠ groupMajority line: For
17 Sept 2026An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector Final vote — text as a wholeAdopted 514 for, 61 against, 33 abstainedPosition: For Majority line: For
17 Sept 2026An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector Amendment 3, adding text after paragraph 55 197 for, 400 against, 9 abstainedPosition: Against Majority line: Against
17 Sept 2026An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector Amendment 2, adding text after paragraph 29 189 for, 387 against, 23 abstainedPosition: Against Majority line: Against
17 Sept 2026An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector Separate vote on paragraph 17 487 for, 45 against, 66 abstainedPosition: For Majority line: For
17 Sept 2026Post-electoral repression in Zambia and the killing of Mutotwe Kafwaya Final vote on the motion for a resolutionAdopted 562 for, 1 against, 33 abstainedPosition: For Majority line: For
17 Sept 2026An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector Amendment 1, adding text after paragraph 1 195 for, 373 against, 29 abstainedPosition: Against Majority line: Against
17 Sept 2026Political prisoners in Cuba, in particular the case of Félix Navarro and his daughter Saylí Navarro Final vote — text as a wholeAdopted 374 for, 198 against, 19 abstainedPosition: Against Majority line: Against
17 Sept 2026Political prisoners in Cuba, in particular the case of Félix Navarro and his daughter Saylí Navarro Amendment 5 to paragraph 8 145 for, 417 against, 24 abstainedPosition: Against Majority line: Against
17 Sept 2026Political prisoners in Cuba, in particular the case of Félix Navarro and his daughter Saylí Navarro Amendment 4 to paragraph 7 153 for, 424 against, 5 abstainedPosition: Against Majority line: Against
17 Sept 2026Deteriorating situation of media freedom and freedom of expression in Hong Kong following the recent arrest of bookseller Leticia Wong and the convictions of Lee Cheuk-yan and Chow Hang-tung Final vote — text as a wholeAdopted 459 for, 12 against, 86 abstainedPosition: For Majority line: For
17 Sept 2026Deteriorating situation of media freedom and freedom of expression in Hong Kong following the recent arrest of bookseller Leticia Wong and the convictions of Lee Cheuk-yan and Chow Hang-tung Separate vote on paragraph 3 517 for, 8 against, 31 abstainedPosition: For Majority line: For
16 Sept 2026Genetically modified maize MON 87460 Final vote on the motion for a resolutionObjection passed 433 for, 159 against, 10 abstainedPosition: For Majority line: For
16 Sept 2026Genetically modified soybean MON 94313 Final vote on the motion for a resolutionObjection passed 457 for, 184 against, 10 abstainedPosition: For Majority line: For
16 Sept 2026Genetically modified soybean GMB151 x DAS-44406-6 Final vote on the motion for a resolutionObjection passed 442 for, 184 against, 12 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Final vote — text as a wholeAdopted 390 for, 218 against, 29 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on citation 19 359 for, 210 against, 81 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on citation 9 353 for, 204 against, 79 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Recital AC — part 2 311 for, 309 against, 21 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Recital AC — part 1 466 for, 128 against, 40 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on recital AB 354 for, 205 against, 89 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on recital AA 362 for, 208 against, 79 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on recital Z 431 for, 165 against, 50 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Recital J — part 2 335 for, 279 against, 23 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Recital J — part 1 509 for, 115 against, 17 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on recital D 593 for, 37 against, 16 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Recital B — part 2 411 for, 213 against, 21 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Recital B — part 1 395 for, 179 against, 63 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 63 — part 3 351 for, 272 against, 28 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 63 — part 2 429 for, 153 against, 69 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 63 — part 1 460 for, 129 against, 64 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 62 — part 3 325 for, 296 against, 33 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 62 — part 2 446 for, 138 against, 59 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 62 — part 1 450 for, 168 against, 37 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 60 386 for, 230 against, 40 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 48 — part 3 322 for, 313 against, 19 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 48 — part 2 409 for, 150 against, 79 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 48 — part 1 510 for, 78 against, 54 abstainedPosition: For Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 25 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within S&D

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
René REPASI S&DGermany98 % of 4 172 shared93 %
Gabriele BISCHOFF S&DGermany97 % of 4 319 shared93 %
Tobias CREMER S&DGermany97 % of 4 120 shared93 %
Jens GEIER S&DGermany97 % of 3 908 shared93 %
Katarina BARLEY S&DGermany97 % of 3 157 shared93 %
Vivien COSTANZO S&DGermany97 % of 4 360 shared93 %
Udo BULLMANN S&DGermany97 % of 3 698 shared93 %
Matthias ECKE S&DGermany97 % of 4 089 shared93 %
Birgit SIPPEL S&DGermany97 % of 3 778 shared93 %
Delara BURKHARDT S&DGermany97 % of 3 492 shared93 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Gerben-Jan GERBRANDY RenewNetherlands90 % of 4 388 shared86 %
Raquel GARCÍA HERMIDA-VAN DER WALLE RenewNetherlands89 % of 4 390 shared86 %
Martin HOJSÍK RenewSlovakia89 % of 4 146 shared86 %
Ľudovít ÓDOR RenewSlovakia89 % of 4 126 shared86 %
Yvan VEROUGSTRAETE RenewBelgium89 % of 3 653 shared86 %
Lucia YAR RenewSlovakia89 % of 4 350 shared86 %
Charles GOERENS RenewLuxembourg89 % of 4 074 shared86 %
Michal WIEZIK RenewSlovakia89 % of 4 083 shared86 %
Jana TOOM RenewEstonia89 % of 3 745 shared86 %
Dainius ŽALIMAS RenewLithuania89 % of 4 091 shared86 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on the Environment, Climate and Food SafetyENVI CommitteeMember20 Jan 2025now
Committee on Legal AffairsJURI CommitteeSubstitute19 Jul 2024now
Committee on Public HealthSANT CommitteeMember23 Jan 2025now
Delegation for relations with South AfricaD-ZA DelegationMember19 Sept 2024now
Intergroup on Trade UnionsIG10-24 Intergroup / working groupMember31 Jan 2025now
Intergroup on the Welfare and Conservation of AnimalsIG10-27 Intergroup / working groupMember8 Jan 2025now
Committee on the Environment, Public Health and Food SafetyENVI CommitteeMember19 Jul 202419 Jan 2025
Subcommittee on Public HealthSANT SubcommitteeMember19 Jul 202419 Jan 2025

Show all 8 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
European Union regulatory fitness and subsidiarity and proportionality – report on Better Law-Making covering 2025 and 2026Shadow rapporteurJURI7 Jul 2026
Replacing S&D shadow rapporteur for the Amending Regulations (EU) 2024/1689 and (EU) 2018/1139 as regards the simplification of the implementation of harmonised rules on artificial intelligence (Digital Omnibus on AI)Trilogue negotiator6 May 2026
Clean corporate vehiclesRapporteurENVI21 Apr 2026
Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex IShadow rapporteurSANT15 Apr 2026
Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act)Opinion rapporteurJURI10 Mar 2026
European Union regulatory fitness and subsidiarity and proportionality – report on Better Law-Making covering 2023 and 2024Shadow rapporteurJURI17 Nov 2025
Amending Directives 2000/14/EC, 2011/65/EU, 2013/53/EU, 2014/29/EU, 2014/30/EU, 2014/31/EU, 2014/32/EU, 2014/33/EU, 2014/34/EU, 2014/35/EU, 2014/53/EU, 2014/68/EU and 2014/90/EU of the European Parliament and of the Council as regards digitalisation and common specificationsShadow rapporteur for an opinionENVI21 Oct 2025
Amending Regulations (EU) No 765/2008, (EU) 2016/424, (EU) 2016/425, (EU) 2016/426, (EU) 2023/1230, (EU) 2023/1542 and (EU) 2024/1781 as regards digitalisation and common specificationsShadow rapporteur for an opinionENVI21 Oct 2025
Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795Shadow rapporteur for an opinionENVI23 Jun 2025
Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795Shadow rapporteurSANT21 May 2025

Show all 23 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

26 contributions recorded; 2 on behalf of their group; 35 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
DateDebateKindVerbatim
16 Sept 2026Stop gold-plating, relieve SMEs: Member States must implement EU legislation without adding extra bureaucracy (topical debate) Speech · 1 minRead
8 Jul 2026EU’s response and preparedness to protect people against recurring heatwaves and upcoming wildfires (debate) Speech · 1 minRead
21 May 2026Need for an adaptation of the EU legal framework on sustainable biofuels (debate) Speech · 1 minRead
21 May 2026European Citizens’ Initiative ‘Stop destroying videogames’ (debate) Speech · 1 minRead
21 May 2026European Citizens’ Initiative ‘Stop destroying videogames’ (debate) Speech · 1 minRead
21 May 2026European Citizens’ Initiative ‘Stop destroying videogames’ (debate) Speech · 1 minRead
20 May 2026Reviewing the ETS system to support European competitiveness (topical debate) Speech · 2 minRead
28 Apr 2026Enforcement of the Digital Markets Act (debate) Speech · 1 minRead
28 Apr 2026Presentation of the Better Regulation and Enforcement Communication (debate) on behalf of S&DSpeech · 1 minRead
8 Oct 2025Europe’s automotive future – reversing the ban on the sale of combustion cars in the EU (topical debate) Speech · 2 minRead

Show all 26 recent contributions

Questions and motions, 20

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
14 Sept 2026Exclusion of purchases of Russian sable pelts from EU sanctions E-10-2026-003651Written questionwith 13 co-authorsNot yet answered
1 Jul 2026PROPOSAL FOR A DECISION requesting the Authority for European Political Parties and European Political Foundations to verify whether Europe of Sovereign Nations Party complies with the conditions laid down in Article 3(1), points (d) and (e), of Regulation (EU, Euratom) 2025/2445 B-10-2026-0338Motion for a resolutionwith 246 co-authors—
10 Jun 2026Potential conflict of interest in the appointment of the Special Envoy for Industrial AI P-10-2026-002401Priority written questionwith 37 co-authors13 Aug 2026
19 May 2026Biofuels and e-fuels in road transport E-10-2026-002077Written questionwith 5 co-authors14 Jul 2026
15 Apr 2026Cali fund – follow up from COP16 UN Convention on Biodiversity O-10-2026-000017Oral questionwith 2 co-authorsNot yet answered
23 Mar 2026MOTION FOR A RESOLUTION on the Commission delegated regulation of 3 February 2026 supplementing Regulation (EU) 2024/3012 of the European Parliament and of the Council by establishing the certification methodologies for permanent carbon removals activities B-10-2026-0181Motion for a resolutionwith 2 co-authors—
20 Feb 202612 months extension of the Supplementary Protection Certificate within the proposed European Biotech Act P-10-2026-000725Priority written question13 Apr 2026
3 Feb 2026Ensuring patient safety for all Europeans: the need to establish a warning system for disqualified medical professionals E-10-2026-000428Written questionwith 24 co-authors27 Mar 2026
5 Nov 2025Better regulation P-10-2025-004346Priority written question6 Jan 2026
5 Sept 2025A standardised LEZ sticker for cars E-10-2025-003461Written questionwith 3 co-authors8 Dec 2025

Show all 20 questions and motions

Amendments tabled in committee, 75

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887 SANT51
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891 SANT85
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791890 SANT66
15 Jul 2026General budget of the European Union for the financial year 2027 - all sections SANT-AM-789117 SANT18
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790937 CJ5320
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934 CJ5332
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790939 CJ5313
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790933 CJ5335
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790953 CJ5324
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790005 CJ5310

Show all 75 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Germany National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Tiemo WÖLKEN”. Member record. memberId 185619. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/185619?page=3&scope=final&vscope=all (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/185619. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/185619?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-185619,
  author = {{EU Parl Watch Research}},
  title = {{Tiemo WÖLKEN}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/185619?page=3&scope=final&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/185619?page=3&scope=final&vscope=all},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 185619. Official source: https://www.europarl.europa.eu/meps/en/185619. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}